Note: Ingredients listed on restricted chemical lists
EC/CAS
63-42-3
Name of the chemical
Lactose C12H22O11
Concentration
N/A
EC/CAS
9004-65-3
Name of the chemical
methylhydroxypropylcellulose
Concentration
N/A
EC/CAS
13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
<=0.84
General Information
Revision date
2021-10-20
Product name
XELODA(R) Tablets (500 mg)
Product Synonyms
XELODA Film Coated Tablets 500mg XELODA F.C. Tablets 500mg
1.2.1 Relevant identified uses
Formulated pharmaceutical active substance
supplier name
Genentech, Inc
Emergency telephone
001-(650) 225-1000, (800)-424-9300
Icons in SDS
Company Information
company name
Genentech, Inc
e-mail address of the competent person responsible for the Safety Data Sheet
info.sds@roche.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H341, H350, H360FD
Hazard statements
Code
Statements
H341
Suspected of causing genetic defects
Section 2
SECTION 2: Hazards identification
Signal word
Danger
Hazard statements
H341 Suspected of causing genetic defects. H350 May cause cancer. H360FD May damage fertility. May damage the unborn child.
Prevention
P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection.
Response
P308 + P313 IF exposed or concerned: Get medical advice/ attention.
Storage
P405 Store locked up.
Disposal
P501 Dispose of contents/ container to an approved waste disposal plant.
Other hazards
None known
2.1 Classification of the substance or mixture
Germ cell mutagenicity : Category 2 Carcinogenicity : Category 1B Reproductive toxicity : Category 1B
